HCPLive

Hepatitis C
The MD Magazine Hepatitis C condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

World Hepatitis Day to Increase Awareness of Hepatitis Virus
July 28 is World Hepatitis Day. The organizers of the awareness campaign are using a variety of channels, including social media, to educate and inform patients and clinicians about hepatitis prevention and treatment.
While alternative and complimentary medicine make their way closer to the mainstream there are still some areas of concern with using them while treating hepatitis C. There have also been questions raised about the costs associated with using new medications to treat the disease.
Awareness-raising day included events throughout the country aimed at reducing the high incidence of infection among people in black communities.
Patients with hepatitis C may not be diagnosed with the condition until their liver damage has progressed to the point of needing a transplant. They may also be suffering from renal failure which requires a different look at treatment options in order to improve overall health.
In the United States genotypes 1 and 2 may be the most common forms of the disease but there are many others, each with their own treatment options and availabilities to patients.
Patients with hepatitis C can go years without having any idea of their condition. Identifying these patients and getting them the treatment they need has become a growing focus in the medical community over the past several years.
The US Food and Drug Administration (FDA) today approved daclatasvir (Daklinza/ Bristol-Myers Squibb) for use with sofosbuvir for the treatment of hepatitis C virus (HCV) genotype 3 infections.

Most Popular

$vacMongoViewPlus$ $vAR$